AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 24998106
Drug: WHO analgesic
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WHO analgesic ladder (non-opioids, weak opioids, strong opioids)
Trial: 20538867
Drug: Spironolactone 25
RxNorm normalized name: spironolactone 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone 25 mg per day
Trial: 18800887
Drug: Honey-comparable glucose-fructose
RxNorm normalized name: fructose / glucose / phosphoric acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Honey-comparable glucose-fructose solution
Trial: 87830
Drug: Adsorbed vaccine
RxNorm normalized name: Tetanus toxoid adsorbed vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adsorbed vaccine
Trial: 23547212
Drug: Presence of
RxNorm normalized name: Dna Plasmid Expressing Diphtheria Toxin Triggered By The Presence Of Oncofetal Gene H19
DrugBank: Inodiftagene vixteplasmid (DB16017)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Presence of anticitrullinated protein antibodies
Trial: 8425236
Drug: Flumazenil (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flumazenil (0.5 mg)
Trial: 16765796
Drug: Vancomycin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vancomycin (20 microg/mL) and gentamicin (8 microg/mL) in the infusion fluid
Trial: 3596865
Drug: Ciba‐Geigy preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciba‐Geigy preparation
Trial: 29288510
Drug: Treatment-as-usual (psychopharmacotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment-as-usual (psychopharmacotherapy only)
Trial: 24620855
Drug: Oral therapy
RxNorm normalized name: RelieVRx Virtual Reality Behavioral Therapy for Pain Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral therapy with Repaglinide
Trial: 1609377
Drug: Auranofin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auranofin (3 mg twice daily)
Trial: 30077184
Drug: Early treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early treatment with ibuprofen (COXi) between 24 and 72 hours postnatal age
Trial: 24549548
Drug: Citalopram (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram (10 mg per day titrated to 30 mg per day over 9 weeks)
Trial: 9190324
Drug: Buprenorphine 0.6mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine 0.6mg/day (sublingual)
Trial: 3117236
Drug: somatrem (methionyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: somatrem (methionyl growth hormone)
Trial: 26495319
Drug: Propofol (target-controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (target-controlled infusion)
Trial: 19211665
Drug: After 12-week
FDA approved: no
EMA approved: no
PMDA approved: no
Description: After 12-week treatment
Trial: 29798336
Drug: Radiotherapy and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiotherapy and chemotherapy combined with cetuximab
Trial: 17941869
Drug: Diet alone,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet alone, diet followed by metformin, or metformin alone
Trial: 15852991
Drug: Melatonin 0.5
RxNorm normalized name: melatonin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 0.5 mg kg(‐1)
Trial: 15852991
Drug: Midazolam 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.25 mg kg(‐1)
Trial: 22315765
Drug: Midazolam 0.5
RxNorm normalized name: midazolam 0.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.5 mg kg(‐1)
Trial: 29695183
Drug: Bacillus coagulans
RxNorm normalized name: Bacillus coagulans
DrugBank: Bacillus coagulans (DB19246)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bacillus coagulans Unique IS2 chewable tablets
Trial: 27040087
Drug: Testosterone (intramuscular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone (intramuscular injection of testosterone undecylate for 4 months)
Trial: 11134978
Drug: Black currant
RxNorm normalized name: Black currant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Black currant anthocyanosides (BCA) 50 mg/subject
Trial: 1397814
Drug: Home visits
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Home visits focusing on smoking, drug and nutrition education, support, and links with community services
Trial: 20602712
Drug: Tapentadol ER
RxNorm normalized name: tapentadol Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tapentadol ER (100 to 250 mg bid)
Trial: 20602712
Drug: Oxycodone CR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone CR (20 to 50 mg bid)
Trial: 18047650
Drug: Manual therapy,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual therapy, exercise and advice without traction
Trial: 7892983
Drug: Oxygen therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxygen therapy for 24 hours followed by continuation for 3 days (Group 1)
Trial: 7892983
Drug: Oxygen therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxygen therapy for 3 days (Group 3)
Trial: 7892983
Drug: No oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No oxygen therapy (Group 4)
Trial: 3034541
Drug: CMV hyperimmunoglobulin
RxNorm normalized name: CMV-immune globulin
DrugBank: Human cytomegalovirus immune globulin (DB13886)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CMV hyperimmunoglobulin (CMV-Polyglobin) administered intravenously at 2 ml/kg bodyweight at three-week intervals up to day 105 after kidney transplantation
Trial: 9787686
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no infusions)
Trial: 1097478
Drug: Penfluridol, administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Penfluridol, administered in a dosage of 40 to 80 mg once a week
Trial: 1097478
Drug: Neuroleptics requiring
RxNorm normalized name: hyaluronic acid Ophthalmic Gel [Optimend Corneal Repair]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuroleptics requiring daily administration
Trial: 31470091
Drug: Stereotactic Ablative
RxNorm normalized name: ABL
DrugBank: Lauric acid (DB03017)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stereotactic Ablative Radiation Therapy (SABR)
Trial: 24274342
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment including therapeutic hypothermia initiated after hospital admission
Trial: 21555501
Drug: CLON‐XR plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CLON‐XR plus stimulant
Trial: 21555501
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus stimulant
Trial: 19002433
Drug: Omega-3 EE90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 EE90 (2 g/day)
Trial: 9109229
Drug: Combination chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapy given preoperatively
Trial: 9109229
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy and chemotherapy given preoperatively
Trial: 8197612
Drug: 2x 100
RxNorm normalized name: Ryna-12X 100mg-5mg-30mg/5ml Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2x 100 mg/day CsA from day 0
Trial: 8197612
Drug: 2x 200
RxNorm normalized name: Hytuss 2X 200 MG Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2x 200 mg/day CsA from day 4
Trial: 3070179
Drug: Intramuscular emulsified
RxNorm normalized name: diazepam
DrugBank: Diazepam (DB00829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular emulsified disulfiram
Trial: 25048646
Drug: Nondrug, nonoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nondrug, nonoperative interventions (e.g., weight loss, shoe orthoses)
Trial: 21804624
Drug: Routine preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine preparation for venipuncture (Control group)
Trial: 26699899
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no statin treatment)
Trial: 16595583
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate (CC) during the whole study period (3 years)
Trial: 3370063
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg i.v. over 1 h
Trial: 3370063
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg p.o.
Trial: 29089192
Drug: Anti-staphylococcal vaccine
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-staphylococcal vaccine
Trial: 6117682
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no vaccine)
Trial: 25837193
Drug: Ropivacaine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine plus 5 μg of sufentanil (group RS)
Trial: 16544586
Drug: Cluster up-dosing
RxNorm normalized name: cluster fig extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cluster up-dosing scheme (3 weeks duration, 19 patients)
Trial: 16544586
Drug: Traditional up-dosing
RxNorm normalized name: Q-Up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional up-dosing scheme (13 weeks duration, 19 patients)
Trial: 16544586
Drug: Cluster up-dosing
RxNorm normalized name: cluster fig extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cluster up-dosing scheme
Trial: 12727580
Drug: Estrogen/progestin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen/progestin therapy (17beta-estradiol [1 mg/d] combined with norethisterone acetate [0.5 mg/d])
Trial: 2856903
Drug: Oxmetidine, 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxmetidine, 600 mg bedtime
Trial: 31246796
Drug: Liposomal bupivacaine
RxNorm normalized name: bupivacaine liposome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liposomal bupivacaine (266 mg)
Trial: 31246796
Drug: Conventional bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional bupivacaine (75 mg)
Trial: 17684364
Drug: DIC 75
RxNorm normalized name: DIC
DrugBank: Dacarbazine (DB00851)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: DIC 75 mg/day plus GGA 150 mg/day for 2 weeks
Trial: 17684364
Drug: DIC 75
RxNorm normalized name: DIC
DrugBank: Dacarbazine (DB00851)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: DIC 75 mg/day plus placebo (lactose 1.5 g/day) for 2 weeks
Trial: 86665
Drug: medical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: medical treatment
Trial: 25464680
Drug: Electro acupuncture
RxNorm normalized name: ELECTRODE SPRAY,ELECTRO MIST
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electro acupuncture therapy (10 sittings over 30 days)
Trial: 25464680
Drug: Conventional drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional drug therapy (oral flunarizine 20 mg OD and paracetamol 500 mg SOS for 30 days)
Trial: 9650124
Drug: Theophylline (165
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (165 mg)
Trial: 3378856
Drug: Tizanidine 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tizanidine 3 mg
Trial: 3378856
Drug: Tizanidine 6
RxNorm normalized name: tizanidine 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tizanidine 6 mg
Trial: 29227845
Drug: Pill placebo
RxNorm normalized name: placebo Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pill placebo during 12-session exposure-based group CBT
Trial: 29129190
Drug: Cognitive behavior
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavior therapy (CBT) protocol for AUD, sessions five and six of a 12-session protocol
Trial: 24569031
Drug: Intracoronary infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary infusion of bone marrow-derived cells (BMCs)
Trial: 17261891
Drug: Blueberin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blueberin (300 mg, 3 times per day for 4 weeks)
Trial: 13129472
Drug: Capsaicin (135
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsaicin (135 mg capsaicin/d)
Trial: 1349757
Drug: Fluspirilene (0.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluspirilene (0.5, 1.0, or 1.5 mg per week)
Trial: 1349757
Drug: Fluspirilene (max
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluspirilene (max 1.5 mg/week)
Trial: 27181277
Drug: Intensive therapy
RxNorm normalized name: Cortaid Intensive Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive therapy group (IT group; n = 22) - combined moderate intensity aerobic and resistance training three times per week for 12 weeks
Trial: 27181277
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy group (CT group; n = 20) - metformin and diet control
Trial: 18633048
Drug: parecoxib 20
RxNorm normalized name: parecoxib 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: parecoxib 20 mg bid
Trial: 18633048
Drug: parecoxib 20
RxNorm normalized name: parecoxib 20 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: parecoxib 20 mg qd
Trial: 12354679
Drug: Multivitamin-multimineral supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multivitamin-multimineral supplementation (VITALIA-tablets)
Trial: 10192755
Drug: Fluvoxamine 50
RxNorm normalized name: fluvoxamine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvoxamine 50 mg as a single oral dose
Trial: 10192755
Drug: Caffeine 200
RxNorm normalized name: caffeine 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine 200 mg as a single oral dose
Trial: 2197382
Drug: Rectal midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Rectal midazolam 0.45 mg/kg
Trial: 6117434
Drug: Oral ranitidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ranitidine administration
Trial: 6117434
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg body wt ranitidine infusion
Trial: 28124736
Drug: High flow
RxNorm normalized name: Blood Set High Flow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High flow nasal cannula (HFNC) at 2 L/kg/min oxygen therapy
Trial: 26103129
Drug: Control (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (4 g olive oil daily for 8 weeks)
Trial: 25816050
Drug: Rosuvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin (40 mg/d)
Trial: 17106937
Drug: CIFN in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CIFN in combination with ribavirin
Trial: 19608530
Drug: Valacyclovir 500
RxNorm normalized name: valacyclovir 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valacyclovir 500 mg once daily
Trial: 11724461
Drug: Dietary treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary treatment (specific dietary fatty acids not detailed)
Trial: 8020175
Drug: Prophylactic ceftriaxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic ceftriaxone administration (Group A)
Trial: 8020175
Drug: Other antibiotics
RxNorm normalized name: Other antibiotics for topical use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other antibiotics (Group C)
Trial: 8020175
Drug: No antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antibiotics (Group D)
Trial: 8020175
Drug: Prophylactic ceftriaxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic ceftriaxone administration (Group A) - Newborns
Trial: 31812890
Drug: Alectinib 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alectinib 300 mg twice daily
Trial: 24102964
Drug: Low-dose dobutamine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose dobutamine (10 μg/kg per min)
Trial: 17323592
Drug: Clopidogrel plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel plus Aspirin (dual antiplatelet therapy)
Trial: 27423556
Drug: Aspirin (monotherapy)
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin (monotherapy)
Trial: 10923282
Drug: Drospirenone alone
RxNorm normalized name: Drospirenone
DrugBank: Drospirenone (DB01395)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Drospirenone alone (0.5-3.0 mg/day for one cycle)
Trial: 10923282
Drug: Ethinylestradiol (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethinylestradiol (30 micrograms) + Drospirenone (2 mg or 3 mg for three cycles)
Trial: 10923282
Drug: Ethinylestradiol (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethinylestradiol (30 micrograms) + Drospirenone (3 mg)
Trial: 15965309
Drug: Entacapone 200
RxNorm normalized name: entacapone 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Entacapone 200 mg
Trial: 4096058
Drug: Haemodynamically oriented
RxNorm normalized name: Oriental melon
DrugBank: Muskmelon (DB15611)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haemodynamically oriented differential therapy
Trial: 30134289
Drug: Continuation of
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuation of nonintegrase inhibitor regimen
Trial: 31594200
Drug: High Intensity
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High Intensity Laser Therapy (HILT)
Trial: 24356596
Drug: Intensive diabetes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive diabetes therapy (INT)
Trial: 11773299
Drug: Paclitaxel-based adjuvant
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel-based adjuvant chemotherapy
Trial: 9649976
Drug: 10-day lofexidine
RxNorm normalized name: LOFEXIDINE
DrugBank: Lofexidine (DB04948)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 10-day lofexidine treatment
Trial: 28268215
Drug: Buprenorphine oral
RxNorm normalized name: buprenorphine Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine oral lyophilisate (bup-lyo)
Trial: 28268215
Drug: Buprenorphine sublingual
RxNorm normalized name: buprenorphine Sublingual Tablet
DrugBank: Buprenorphine (DB00921)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Buprenorphine sublingual tablets (bup-SL)
Trial: 16765759
Drug: Clopidogrel (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (75 mg per day) plus aspirin (75-100 mg per day)
Trial: 16765759
Drug: Oral anticoagulation
RxNorm normalized name: monitoring agent for oral anticoagulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anticoagulation therapy (for patients already receiving treatment at study entry)
Trial: 16765759
Drug: Clopidogrel plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel plus aspirin (for patients not on oral anticoagulation therapy at study entry)
Trial: 11895463
Drug: Intracoronary treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracoronary treatment with oestrogen (group 2)
Trial: 10102427
Drug: IFN‐alpha2a treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN‐alpha2a treatment
Trial: 363490
Drug: Sulfonylurea or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfonylurea or insulin treatment
Trial: 26067585
Drug: ABT-639 (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT-639 (100 mg twice daily)
Trial: 7846309
Drug: High-dose group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose group (2.0 g of soil/day)
Trial: 2898400
Drug: Iron dextran
RxNorm normalized name: Iron Dextran
DrugBank: Iron Dextran (DB00893)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron dextran (Imferon) administered by total dose infusion (TDI) at high dose
Trial: 2898400
Drug: Iron dextran
RxNorm normalized name: Iron Dextran
DrugBank: Iron Dextran (DB00893)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron dextran (Imferon) administered by total dose infusion (TDI) at low dose
Trial: 31452382
Drug: Concomitant treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concomitant treatments for non-communicable diseases (NCD)
Trial: 25225010
Drug: Palliative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palliative chemotherapy (three courses)
Trial: 17059933
Drug: Papaverine injection
RxNorm normalized name: papaverine Injection
DrugBank: Papaverine (DB01113)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Papaverine injection into the endothoracic fascia (Group 2)
Trial: 17059933
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of papaverine and carbon dioxide (Group 4)
Trial: 9324179
Drug: Ketorolac by
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac by bolus plus infusion (Ket I)
Trial: 30413151
Drug: Galcanezumab 120
RxNorm normalized name: Galcanezumab 120 mg/mL solution for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galcanezumab 120 mg and 240 mg
Trial: 24239201
Drug: Clopidogrel with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel with calcium-channel blockers (CCBs)
Trial: 24239201
Drug: Clopidogrel with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel with CCB and atorvastatin 80 mg daily
Trial: 24239201
Drug: Clopidogrel with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel with CCB, statin, and proton pump inhibitor
Trial: 12720542
Drug: Vaginal progesterone
RxNorm normalized name: progesterone Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal progesterone 800 mg/day